
Saniona Investor Relations Material
Latest events

Status Update
Saniona
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Saniona
Access all reports
Saniona AB is a clinical-stage biopharmaceutical company based in Denmark, focused on the discovery and development of treatments for central nervous system, autoimmune, metabolic diseases, and pain management. The company specializes in modulating ion channels, a class of proteins critical in cellular signaling. Saniona has built a proprietary drug discovery platform that includes more than 20,000 ion channel-modulating molecules. The company is headquartered in Ballerup, Denmark, and its shares are listed on the Nasdaq Stockholm.
Latest articles
)
Lowe's Companies: Building a One-Stop Shop for Home Improvement
Lowe's Companies began as a single store in 1921 and has steadily expanded its footprint and offerings, now operating 1,750 stores across the U.S.
7 May 2025
)
Greg Abel: Succeeding Warren Buffett at Berkshire Hathaway
After decades working with Warren Buffett and Charlie Munger, Greg Abel was named Buffett’s successor as he steps down in late 2025.
5 May 2025
)
Intuitive Surgical: Enhancing Surgery with Robotic Precision
Intuitive Surgical has revolutionized surgery with robotics, building its dominant position through decades of innovation, validation, and expansion.
2 May 2025
Ticker symbol
SANION
Country
🇸🇪 Sweden